BP 04
Latest Information Update: 20 Dec 2016
At a glance
- Originator BioPhausia
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 22 Mar 2007 Discontinued - Preclinical for Cancer in Norway (unspecified route)
- 22 Mar 2007 Discontinued - Preclinical for Cancer in Sweden (unspecified route)
- 14 Feb 2001 Profile reviewed but no significant changes made